Cargando…

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

BACKGROUND: The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner drugs to preserve chloroquine effica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laufer, Miriam K., Thesing, Phillip C., Dzinjalamala, Fraction K., Nyirenda, Osward M., Masonga, Rhoda, Laurens, Matthew B., Stokes-Riner, Abbie, Taylor, Terrie E., Plowe, Christopher V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422316/ https://www.ncbi.nlm.nih.gov/pubmed/22912697 http://dx.doi.org/10.1371/journal.pone.0042284

Ejemplares similares

Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment
por: Shaukat, Ayesha M, et al.
Publicado: (2012)

Atovaquone/proguanil‐induced autoimmune‐like hepatitis
por: Terziroli Beretta‐Piccoli, Benedetta, et al.
Publicado: (2017)

Plasmodium falciparum Malaria and Atovaquone-Proguanil Treatment Failure
por: Durand, Rémy, et al.
Publicado: (2008)

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021)

Tolerability of Atovaquone—Proguanil Application in Common Buzzard Nestlings
por: Wiegmann, Anja, et al.
Publicado: (2022)

A survey on outcomes of accidental atovaquone–proguanil exposure in pregnancy
por: Tan, Kathrine R., et al.
Publicado: (2018)

Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
por: Skinner-Adams, Tina S., et al.
Publicado: (2019)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
por: Tommasi, Chiara, et al.
Publicado: (2011)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
por: Nicosia, V, et al.
Publicado: (2008)

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis
por: Staines, Henry M, et al.
Publicado: (2018)

Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study
por: Zhang, Naiqi, et al.
Publicado: (2022)

Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola
por: Pimentel, Sónia, et al.
Publicado: (2006)

Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa
por: Happi, Christian T, et al.
Publicado: (2006)

Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast
por: Wurtz, Nathalie, et al.
Publicado: (2012)

The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment
por: Maude, Richard J, et al.
Publicado: (2014)

Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases
por: Cordel, Hugues, et al.
Publicado: (2013)

Delayed Onset of Symptoms and Atovaquone-Proguanil Chemoprophylaxis Breakthrough by Plasmodium malariae in the Absence of Mutation at Codon 268 of pmcytb
por: Teo, Beatrix Huei-Yi, et al.
Publicado: (2015)

Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine
por: Chalon, Stephan, et al.
Publicado: (2021)

Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum
por: Castañeda-Mogollón, Daniel, et al.
Publicado: (2023)

In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand
por: Khositnithikul, Rommanee, et al.
Publicado: (2008)

Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil
por: Sutherland, Colin J, et al.
Publicado: (2008)

A Safe and Effective Atovaquone-Proguanil Therapeutic Protocol for the Treatment of Avian Malaria by Plasmodium relictum in Snowy Owl (Bubo scandiacus)
por: Pugliese, Nicola, et al.
Publicado: (2023)

Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs
por: Kirk, S.K., et al.
Publicado: (2017)

TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial
por: Laurens, Matthew B., et al.
Publicado: (2016)

Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults
por: Banda, Clifford G., et al.
Publicado: (2018)

Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria
por: Plucinski, Mateusz M., et al.
Publicado: (2014)

Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone–proguanil in traveller returning from Congo
por: Massamba, Laurencie, et al.
Publicado: (2020)

Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone
por: Kletsova, Ekaterina A., et al.
Publicado: (2017)

Cytauxzoon felis cytochrome b gene mutation associated with atovaquone and azithromycin treatment
por: Hartley, Ashley N., et al.
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Timing of Malaria Infection during Pregnancy Has Characteristic Maternal, Infant and Placental Outcomes
por: Kalilani-Phiri, Linda, et al.
Publicado: (2013)

The role of different components of the immune system against Plasmodium falciparum malaria: Possible contribution towards malaria vaccine development
por: Mandala, Wilson L., et al.
Publicado: (2021)

The Efficacy of Artesunate, Chloroquine, Doxycycline, Primaquine and a Combination of Artesunate and Primaquine against Avian Malaria in Broilers
por: SOHSUEBNGARM, Damnern, et al.
Publicado: (2014)

Artesunate: could be an alternative drug to chloroquine in COVID-19 treatment?
por: Uzun, Tuğçenur, et al.
Publicado: (2020)

Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
por: Marcos, Luis A., et al.
Publicado: (2022)

Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy
por: Chico, R Matthew, et al.
Publicado: (2008)

Azithromycin/chloroquine/tacrolimus: Cardiac disorders: case report
Publicado: (2021)

Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
por: Chotsiri, Palang, et al.
Publicado: (2022)

Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets
por: Zhao, Qinying, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l37ae9rntckhdjtam69s3u37ie